Molecure SA
WSE:MOC
Molecure SA?
US |
![]() |
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
US |
![]() |
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
US |
![]() |
Bank of America Corp
NYSE:BAC
|
Banking
|
US |
![]() |
Mastercard Inc
NYSE:MA
|
Technology
|
US |
![]() |
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
US |
![]() |
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
US |
![]() |
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
US |
![]() |
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
US |
![]() |
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
US |
![]() |
Visa Inc
NYSE:V
|
Technology
|
CN |
![]() |
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
US |
![]() |
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
US |
![]() |
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
US |
![]() |
Coca-Cola Co
NYSE:KO
|
Beverages
|
US |
![]() |
Walmart Inc
NYSE:WMT
|
Retail
|
US |
![]() |
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
We'll email you a reminder when the closing price reaches USD.
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.

Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
8.1
17.34
|
Price Target |
|
We'll email you a reminder when the closing price reaches PLN.
Choose the stock you wish to monitor with a price alert.
![]() |
Johnson & Johnson
NYSE:JNJ
|
US |
![]() |
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
![]() |
Bank of America Corp
NYSE:BAC
|
US |
![]() |
Mastercard Inc
NYSE:MA
|
US |
![]() |
UnitedHealth Group Inc
NYSE:UNH
|
US |
![]() |
Exxon Mobil Corp
NYSE:XOM
|
US |
![]() |
Pfizer Inc
NYSE:PFE
|
US |
![]() |
Palantir Technologies Inc
NYSE:PLTR
|
US |
![]() |
Nike Inc
NYSE:NKE
|
US |
![]() |
Visa Inc
NYSE:V
|
US |
![]() |
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
![]() |
3M Co
NYSE:MMM
|
US |
![]() |
JPMorgan Chase & Co
NYSE:JPM
|
US |
![]() |
Coca-Cola Co
NYSE:KO
|
US |
![]() |
Walmart Inc
NYSE:WMT
|
US |
![]() |
Verizon Communications Inc
NYSE:VZ
|
US |
This alert will be permanently deleted.
What unique competitive advantages
does Molecure SA hold over its rivals?
What risks and challenges
does Molecure SA face in the near future?
Is it considered overvalued or undervalued
based on the latest financial data?
Provide an overview of the primary business activities
of Molecure SA.
Provide an overview of the primary business activities
of Molecure SA.
What unique competitive advantages
does Molecure SA hold over its rivals?
What risks and challenges
does Molecure SA face in the near future?
Is it considered overvalued or undervalued
based on the latest financial data?
Show all valuation multiples
for Molecure SA.
Provide P/S
for Molecure SA.
Provide P/E
for Molecure SA.
Provide P/OCF
for Molecure SA.
Provide P/FCFE
for Molecure SA.
Provide P/B
for Molecure SA.
Provide EV/S
for Molecure SA.
Provide EV/GP
for Molecure SA.
Provide EV/EBITDA
for Molecure SA.
Provide EV/EBIT
for Molecure SA.
Provide EV/OCF
for Molecure SA.
Provide EV/FCFF
for Molecure SA.
Provide EV/IC
for Molecure SA.
Show me price targets
for Molecure SA made by professional analysts.
What are the Revenue projections
for Molecure SA?
How accurate were the past Revenue estimates
for Molecure SA?
What are the Net Income projections
for Molecure SA?
How accurate were the past Net Income estimates
for Molecure SA?
What are the EPS projections
for Molecure SA?
How accurate were the past EPS estimates
for Molecure SA?
What are the EBIT projections
for Molecure SA?
How accurate were the past EBIT estimates
for Molecure SA?
Compare the revenue forecasts
for Molecure SA with those of its competitors based on recent analyst estimates.
Compare the intrinsic valuations
of Molecure SA and its key competitors using the latest financial data.
Compare historical revenue growth rates
of Molecure SA against its competitors.
Analyze the profit margins
(gross, operating, and net) of Molecure SA compared to its peers.
Compare the P/E ratios
of Molecure SA against its peers.
Discuss the investment returns and shareholder value creation
comparing Molecure SA with its peers.
Analyze the financial leverage
of Molecure SA compared to its main competitors.
Show all profitability ratios
for Molecure SA.
Provide ROE
for Molecure SA.
Provide ROA
for Molecure SA.
Provide ROIC
for Molecure SA.
Provide ROCE
for Molecure SA.
Provide Gross Margin
for Molecure SA.
Provide Operating Margin
for Molecure SA.
Provide Net Margin
for Molecure SA.
Provide FCF Margin
for Molecure SA.
Show all solvency ratios
for Molecure SA.
Provide D/E Ratio
for Molecure SA.
Provide D/A Ratio
for Molecure SA.
Provide Interest Coverage Ratio
for Molecure SA.
Provide Altman Z-Score Ratio
for Molecure SA.
Provide Quick Ratio
for Molecure SA.
Provide Current Ratio
for Molecure SA.
Provide Cash Ratio
for Molecure SA.
What is the historical Revenue growth
over the last 5 years for Molecure SA?
What is the historical Net Income growth
over the last 5 years for Molecure SA?
What is the current Free Cash Flow
of Molecure SA?
Discuss the annual earnings per share (EPS)
trend over the past five years for Molecure SA.
EV/GP
Enterprise Value to Gross Profit
Market Cap | EV/GP | ||||
---|---|---|---|---|---|
PL |
M
|
Molecure SA
WSE:MOC
|
183.8m PLN | -85.3 | |
US |
![]() |
Eli Lilly and Co
NYSE:LLY
|
779.4B USD | 22 |
|
UK |
![]() |
Dechra Pharmaceuticals PLC
LSE:DPH
|
440.4B GBP | 1 026 |
|
US |
![]() |
Johnson & Johnson
NYSE:JNJ
|
394B USD | 6.6 |
|
DK |
![]() |
Novo Nordisk A/S
CSE:NOVO B
|
2.1T DKK | 8.8 |
|
CH |
![]() |
Roche Holding AG
SIX:ROG
|
236.5B CHF | 5.9 |
|
UK |
![]() |
AstraZeneca PLC
LSE:AZN
|
177B GBP | 55.3 |
|
US |
![]() |
Merck & Co Inc
NYSE:MRK
|
225.9B USD | 4.7 |
|
CH |
![]() |
Novartis AG
SIX:NOVN
|
199.7B CHF | 6.2 |
|
IE |
E
|
Endo International PLC
LSE:0Y5F
|
167.6B USD | 111.2 |
|
US |
![]() |
Pfizer Inc
NYSE:PFE
|
142.8B USD | 4.2 |
|
PL |
M
|
Molecure SA
WSE:MOC
|
Average EV/GP:
125.1
|
|
US |
![]() |
Eli Lilly and Co
NYSE:LLY
|
22
|
|
UK |
![]() |
Dechra Pharmaceuticals PLC
LSE:DPH
|
1 026
|
|
US |
![]() |
Johnson & Johnson
NYSE:JNJ
|
6.6
|
|
DK |
![]() |
Novo Nordisk A/S
CSE:NOVO B
|
8.8
|
|
CH |
![]() |
Roche Holding AG
SIX:ROG
|
5.9
|
|
UK |
![]() |
AstraZeneca PLC
LSE:AZN
|
55.3
|
|
US |
![]() |
Merck & Co Inc
NYSE:MRK
|
4.7
|
|
CH |
![]() |
Novartis AG
SIX:NOVN
|
6.2
|
|
IE |
E
|
Endo International PLC
LSE:0Y5F
|
111.2
|
|
US |
![]() |
Pfizer Inc
NYSE:PFE
|
4.2
|
|
EV/GP Forward Multiples
Forward EV/GP multiple is a version of the EV/GP ratio that uses forecasted gross profit for the EV/GP calculation. 1-Year, 2-Years, and 3-Years forwards use gross profit forecasts for 1, 2, and 3 years ahead, respectively.